Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis Source: Eur Respir J 2003; 21: 25-30 Year: 2003
Risk of venous thromboembolism (VTE) in first degree relatives (FDRS) of patients with unprovoked VTE who do not have factor V Leiden (FVL) or the G20210A prothrombin gene mutation (PGM) Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Prothrombin gene variant (20210A) as cause of thromboembolic events in a young pregnant woman Source: Eur Respir J 2001; 18: Suppl. 33, 382s Year: 2001
The impact of screening for factor V Leiden (FVL) first degree relatives of patients with venous thromboembolism (VTE) and FVL on their risk of VTE Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010
The role of thrombophilic risk factors in the severity of pulmonary thromboembolism Source: Eur Respir J 2002; 19: 709-711 Year: 2002
Massive pulmonary embolism as the first manifestation in a patient with double heterozygocity for MTHFR and prothrombin 20210 G/A Source: Eur Respir J 2003; 22: Suppl. 45, 443s Year: 2003
Prothrombin 20210 G/A mutation and EPCR I/D polymorphisms were rare in patients with pulmonary thromboembolism in Chinese Han population Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020 Year: 2020
PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012
Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL) Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2008; 31: 736-741 Year: 2008
The relationship between polymorphisms of fibrinogen beta gene and pulmonary thromboembolism in Chinese Han population Source: Eur Respir J 2006; 28: Suppl. 50, 400s Year: 2006
Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE) Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005
Contribution of thrombophilic genetic factors in development and recurrent manifestation of pulmonary embolism in young patients Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005
The importance of high plasma levels of factor VIIIc in the severity of pulmonary thromboembolism Source: Eur Respir J 2001; 18: Suppl. 33, 252s Year: 2001
First identification of Krüppel-like factor 2 mutation in heritable pulmonary arterial hypertension Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017
Late-breaking abstract: Significant association between protein C promoter region polymorphism and susceptibility to pulmonary thromboembolism in a Chinese Han population Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011
D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006
The genetic risk factors for the recurrent pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 100s Year: 2005
The acquired and inherited risk factors in venous thromboembolism (VTE) Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003